Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Phase Ib Study of Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors.

Tolcher AW, Sznol M, Hu-Lieskovan S, Papadopoulos KP, Patnaik A, Rasco DW, Di Gravio D, Huang B, Gambhire D, Chen Y, Thall AD, Pathan N, Schmidt EV, Chow LQM.

Clin Cancer Res. 2017 Sep 15;23(18):5349-5357. doi: 10.1158/1078-0432.CCR-17-1243. Epub 2017 Jun 20.

2.

Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives.

Subbiah V, Chuang HH, Gambhire D, Kairemo K.

Diagnostics (Basel). 2017 Feb 15;7(1). pii: E10. doi: 10.3390/diagnostics7010010.

3.

Factors associated with early relapse to insulin dependence in unprovoked A-β+ ketosis-prone diabetes.

Gaba R, Gambhire D, Uy N, Gonzalez EV, Iyer D, Hampe CS, Ram N, Balasubramanyam A.

J Diabetes Complications. 2015 Sep-Oct;29(7):918-22. doi: 10.1016/j.jdiacomp.2015.04.013. Epub 2015 Apr 30.

4.

A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V).

Pai V, Paneerselvam A, Mukhopadhyay S, Bhansali A, Kamath D, Shankar V, Gambhire D, Jani RH, Joshi S, Patel P.

J Diabetes Sci Technol. 2014 Jan;8(1):132-141. Epub 2014 Jan 16.

5.

Neuropsychiatric symptoms in mild cognitive impairment: An analysis and its impact on caregiving.

Trivedi SC, Subramanyam AA, Pinto C, Gambhire DD.

Indian J Psychiatry. 2013 Apr;55(2):154-60. doi: 10.4103/0019-5545.111454.

Supplemental Content

Loading ...
Support Center